Akalin H E
Pfizer Pharmaceutical Group, Ortaköy, Istanbul, Turkey.
Drugs. 1999;58 Suppl 2:52-4. doi: 10.2165/00003495-199958002-00010.
Typhoid fever is a severe systemic disease. Treatment with appropriate antibiotics is essential for enteric fever. Development and rapid dissemination of resistance to chloramphenicol, ampicillin, and cotrimoxazole have complicated the treatment of enteric fever. Therapeutic options for the treatment of multidrug-resistant strains are limited to third generation cephalosporins or fluoroquinolone antibiotics. Recent clinical experiences have shown that quinolones are the drugs of choice for treatment of enteric fever. Studies have shown that shorter courses may be sufficient to cure uncomplicated typhoid fever.
伤寒热是一种严重的全身性疾病。使用适当的抗生素进行治疗对于肠热病至关重要。对氯霉素、氨苄西林和复方新诺明耐药性的出现和迅速传播使肠热病的治疗变得复杂。治疗多重耐药菌株的治疗选择仅限于第三代头孢菌素或氟喹诺酮类抗生素。最近的临床经验表明,喹诺酮类药物是治疗肠热病的首选药物。研究表明,较短疗程可能足以治愈无并发症的伤寒热。